Monitor and Review Clause Samples

Monitor and Review. The Memorandum of Understanding (Tier Zero) will be subject to regular formal review by representatives of the partners to this agreement through the HCP S2C Information Governance Strategy Review Group, following changes to law, ethics and policy in relation to the security and confidentiality of information or as a minimum on a bi-annual basis. These reviews will and must be documented within the group’s minutes. The use and effectiveness of the Tier One will be evaluated as follows: • Breaches of GDPR and/or DPA which further result in breaches of the agreement may be logged and reported by any partner organisation (Data Controller and/or Data Processor), including complaints as a result of information sharing. • Breaches of any supplementary individual local agreements (Tier Two) may be logged and reported by any partner organisation, including complaints as a result of information sharing. • Any general difficulties encountered in applying the Tier One may be logged and reported by any partner organisation. • Any such reported breaches/difficulties will form part of the evaluation process, e.g.: o Refusal to share information o Conditions being placed on disclosure o Delays in responding to requests o No legitimate reason for sharing o Poor quality data o Disregard for the Memorandum of Understanding (Tier Zero) o Use of shared information for ‘further’ purpose(s) incompatible with those agreed o Non-compliant security arrangements Responsible officers of the signatory organisations will be notified of any complaint arising from the disclosure of any information in accordance with the Memorandum of Understanding (Tier Zero). All partner organisations will assist each other as necessary in responding to any complaints. The organisation in receipt of the complaint shall use its Complaints Policy and procedure in investigating the complaint.

Monitor and Review. The Council will review this Policy and the effectiveness of its workplace violence and workplace harassment prevention measures at least every year and after any critical incident of violence in the workplace. I have read, understood and agree to abide by the terms of this Workplace Violence and Workplace Harassment Policy. Employee Signature Date of Signature

Monitor and Review. The DMP will maintain regular contact with an employee enrolled in the program to offer support. Frequency of contact will depend, in part, on the likelihood of a return to work and the nature of their illness/injury but will not be more frequent than every thirty (30) calendar days unless otherwise agreed to by the employee.

Monitor and Review. (A) The Contractor shall and shall ensure that its Sub-contractors co-operate with, and provide any information, documentation and assistance reasonably requested by Glencore, in connection with any monitoring and/or audit conducted or requested by Glencore of the requirements of this Schedule B.

Monitor and Review. The WH Monitoring Committee will continue to monitor and review the 12- Hour Shift Roster, commencing from the date of signing of this Agreement. The parties agree the operation of this clause may be reviewed. The WH Monitoring Committee shall consist of: (a) The Unit Manager of a 12-hour shift unit; (b) Employee representative of a 12-hour shift unit; (c) Operations Manager of a 12-hour shift unit; (d) WH Director of Nursing; (e) WH People and Culture Representatives; (f) ANMF Organiser, and (g) Local ANMF Job Representative(s).

Monitor and Review. The Travel Plan will secure an ongoing process of continuous improvement. Each version of the Travel Plan shall set out a mechanism of next steps to be tackled in line with results collated from the surveys and shall also set out a mechanism for reporting back to the Council on an annual basis on how effectively the Travel Plan is being in maximising the use of sustainable transport.

Monitor and Review. A Monitoring Committee will continue to monitor and review the 12 Hour Shift Roster at 3-6 monthly intervals, or as agreed, commencing from the date of commencement of 12 hour shifts. The parties agree the operation of this clause may be reviewed. The Unit Monitoring Committee shall consist of: (1) Director of Clinical Services/Nursing (however titled); (2) The Nurse Unit Manager; and (3) Employee representative, which may at the employee’s request be a Union Representative;

Monitor and Review. 7.1. Non-Compliance (Internal) Instances of internal non-compliance with this ISA will be logged and reported to the appropriate designated person (see Section 4.4). They should be dealt with promptly and in accordance with the relevant organisation’s Information Governance operational policies and procedures. These should be described in the appropriate SOP. Incidents should be logged and reported. These types of incident include, but are not restricted to:  inappropriate refusal to disclose information  'inappropriate conditions being placed on disclosure'  disregard of the information sharing agreement and associated documents and  Disregard of the views and rights of data subjects. 7.2. Non-Compliance (Partner Organisations) Instances of non-compliance with this ISA will be reported to the relevant organisation’s designated person. These instances should be dealt with promptly in accordance with the organisation’s Information Governance operational policies and procedures and should be described in the appropriate SOP. In addition, for both internal and external non-compliance, each organisation shall also inform such regulatory bodies as need to know or they are required to inform of any breaches, for example, the ICO. This should be the responsibility of the designated person. These reporting requirements should also be described in the appropriate SOP. 7.3. Data subject/Practitioner Concerns Any concerns or complaints received from data subjects (or their authorised representatives) relating to the processing/sharing of their personal information should be dealt with promptly in accordance with the organisations complaints procedure and, where appropriate, the conditions outlined in Sections 7.1 and 7.2 and in the appropriate SOP. Any concerns or complaints received from practitioners relating to the operation of this ISA will be referred to their organisation’s designated person who will respond in accordance conditions outlined in Sections 7.1 and

Monitor and Review. For each Trial, SPONSOR or its authorized representatives shall have the right, upon advance written notice, and at mutually agreeable times during regular business hours, to: (a) audit Institution and all Facilities used in performance of the Trial, up to twice per year in the absence of a reasonable for-cause determination by SPONSOR in which case additional audits may be conducted; (b) monitor the conduct of the Trial; (c) review, copy (at SPONSOR’s expense) and audit all Trial Documentation, Source Documents (as defined below), any other nonfinancial books, records, data and Work Product (as defined in Section 15.4) relating to the Trial, and all required licenses, certificates and accreditation; (d) Trial, inspect and test all Trial Devices after explant if such devices were not otherwise returned to SPONSOR; and (e) interview the Principal Investigator and other persons who assisted in performing the Trial. Such audits will be subject to Institution’s policies regarding patient confidentiality. Minimum necessary portions of Subjects' medical records shall be made available to SPONSOR in accordance with the terms of the informed consent form and HIPAA authorization signed by Subjects. Institution Information (as defined in Section 16.4) obtained or reviewed by SPONSOR or its authorized representatives in the course of the audit is subject to the confidentiality obligations set forth in Section 16. For clarity, unless otherwise specified in a SOW and ICF, Institution shall not be required to provide to SPONSOR financial information, economic data such as UB-04 forms, or access to any financial systems or records. SPONSOR acknowledges and Institution represents that Institution maintains reasonable standard premises rules relating to confidentiality, safety, and security that are generally applicable to all persons at Institution Facilities. SPONSOR shall communicate any material findings to Institution and Principal Investigator in an exit meeting and in writing within ten (10) business days after completion of an audit. If SPONSOR intends to disclose (report) any adverse findings about Institution or Principal Investigator to any governmental or regulatory authority, or use audit findings as a basis for termination of an SOW or this Agreement, it shall provide Institution with a copy of such audit report, and a copy of any of the information SPONSOR intends to provide to any governmental or regulatory authority, prior to submission thereof, unless SPO...